Cargando…
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
Nearly 50% of uveal melanoma (UM) patients develop metastatic disease, and there remains no current standard assay for detection of minimal residual disease. We conducted a pilot study to check the feasibility of circulating tumor cell (CTC) detection in UM. We enrolled 40 patients with early or met...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628316/ https://www.ncbi.nlm.nih.gov/pubmed/31226786 http://dx.doi.org/10.3390/cancers11060856 |